| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |